ARTICLE | Company News
RXi Pharmaceuticals, Thera Neuropharma deal
May 16, 2016 7:00 AM UTC
Thera Neuropharma licensed exclusive rights to RXi’s sd-rxRNA platform to develop and commercialize therapeutics for neurodegenerative diseases. Thera Neuropharma plans to initially focus on developin...